Trial intelligence / Profile preview

Blood-saving Effect of Kaolin-based Hemostatic Gauze Combined With Intravenous Tranexamic Acid in Total Knee Arthroplasty

NCT05504577Phase 4Completed

Sponsor
Chang Gung Memorial Hospital
Start
Mar 2022
Primary completion
Jul 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial (3 arms), sponsored by Chang Gung Memorial Hospital. Primary endpoint: Total Blood Loss at 4 days. Started Mar 2022; status: completed.

Beyond the preview

Go deeper on NCT05504577.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05504577.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call